Correlation Between APOBEC3B Expression and Clinical Characterization in Lower-Grade Gliomas

BACKGROUND: As the most aggressive tumors in the central nervous system, gliomas have poor prognosis and limited therapy methods. Immunotherapy has become promising in the treatment of gliomas. Here, we explored the expression pattern of APOBEC3B, a genomic mutation inducer, in gliomas to assess its...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hao, Chen, Zhiyang, Wang, Zeyu, Dai, Ziyu, Hu, Zhengang, Zhang, Xun, Hu, Min, Liu, Zhixiong, Cheng, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033027/
https://www.ncbi.nlm.nih.gov/pubmed/33842328
http://dx.doi.org/10.3389/fonc.2021.625838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033027/
https://www.ncbi.nlm.nih.gov/pubmed/33842328
http://dx.doi.org/10.3389/fonc.2021.625838

Ejemplares similares